Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Removing toxic substances refers to the physiological process of detoxification, which is the body's primary defense mechanism against xenobiotics and harmful metabolic waste (StatPearls, 2023). This complex process is largely mediated by the liver and kidneys through a series of coordinated enzymatic reactions and transport mechanisms (NIH, 2022). Phase I metabolism typically involves oxidation, reduction, or hydrolysis—often by the Cytochrome P450 enzyme family—to expose functional groups, while Phase II involves conjugation to increase water solubility for easier elimination (PubChem, 2024). Phase III involves the active transport of these metabolites out of cells via proteins like P-glycoprotein for eventual excretion in urine or bile (Wikipedia, 2024). Because this term describes a broad functional outcome involving hundreds of different enzymes and transporters rather than a single discrete molecule, it is considered an incorrect entry for a specific therapeutic target.
Not applicable as this is a broad biological process and not a specific molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Removing toxic substances.